BIONOR HOLDING AS

Under liquidation: 07/17/2026, Insolvency proceedings

Liquidation estate:

Å utvikle, kjøpe og eie selskap med vaksiner for kommersialisering herunder videreutvikle alene eller med partner (e) for ut-lisensiering og salg samt annet som naturlig faller sammen med dette.

Forskning og utviklingsarbeid innen bioteknologi.

Organization

Chairman of the board: BS
Birger Sørensen1955
Years since formation: 9 years; since Jul 11, 2017
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 45,582,866; 1 share class
Total number of shareholders: 29; 20 companies, 9 persons
Belongs to group of

Financials

Annual total result 2024: -148,896; NOK
Total equity 2024: -819,407; NOK

Last update: Jul 18, 2026

Management

Board

Name	Role	Shares
BS Birger Sørensen 1955	Chairman	-

Others

Name	Role	Shares
A AIDER AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
AW Arne Wivelstad Dag 1962	-	13.18 % indirectly
SB Sørensen Birger 1955	-	10.72 % indirectly
SS Schjønhaug Susrud Andres 1982	-	8.08 % indirectly
SS Schjønhaug Susrud Helén 1981	-	4.04 % indirectly
KS Kristoffer Sunde Einar 1987	-	3.65 % indirectly
AJ Aslaksdatter Jendal Oda 1993	-	3.34 % indirectly
AJ Aslakssøn Jendal Bård 1991	-	3.34 % indirectly
AJ Aslakssøn Jendal Mads 1988	-	3.34 % indirectly
TS Terje Smerud Knut 1963	-	2.97 % indirectly
HT Hatteland Tommy 1990	-	2.14 % indirectly

Last update: Jun 3, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
I IMMUNOR AS Under liquidation	Ordinary shares	16,350,000	35.87 %
J JAKOB HATTELAND HOLDING AS	Ordinary shares	6,430,669	14.11 %
W WIVEL INVEST AS	Ordinary shares	5,468,181	12 %
A A A HOLDING AS	Ordinary shares	4,568,180	10.02 %
SH Svenska Handelsbanken Ab	Ordinary shares	3,114,658	6.83 %
A APEX CAPITAL AS	Ordinary shares	1,568,180	3.44 %
S SMERUD MEDICAL RESEARCH INTERNATIONAL AS	Ordinary shares	1,275,760	2.8 %
S SOLON EIENDOM AS	Ordinary shares	1,022,705	2.24 %
C CHRISHØEG AS	Ordinary shares	775,902	1.7 %
M MALISE AS	Ordinary shares	775,902	1.7 %
G GRAFO AS	Ordinary shares	681,803	1.5 %
SK Sakai Ken 1978	Ordinary shares	500,000	1.1 %
J JAN INGE SAGEIE AS	Ordinary shares	500,000	1.1 %
F FINNMIN EIENDOM AS	Ordinary shares	419,674	0.92 %
J JARAH INVEST AS	Ordinary shares	262,262	0.58 %
T TRE E FINANS AS	Ordinary shares	250,000	0.55 %
LO Larsen Ottar 1963	Ordinary shares	170,450	0.37 %
IS Ingvald Skaane Tor 1942	Ordinary shares	170,069	0.37 %
AO Anders Olausson Dag 1954	Ordinary shares	153,333	0.34 %
A AROSA INVEST AS	Ordinary shares	141,967	0.31 %
WA Wivelstad Anders 1964	Ordinary shares	140,000	0.31 %
K KAG AS	Ordinary shares	136,360	0.3 %
B BLUE HORIZON AS	Ordinary shares	134,000	0.29 %
MØ Måseidvåg Øystein 1953	Ordinary shares	102,270	0.22 %
A ADIANTE AS	Ordinary shares	100,000	0.22 %
SM Sture Mork Per 1952	Ordinary shares	100,000	0.22 %
R RM CONSULTANTS AS	Ordinary shares	100,000	0.22 %
BS Barfod Sigmond Christian 1959	Ordinary shares	99,164	0.22 %
M MD INVESTMENTS AS	Ordinary shares	71,377	0.16 %

Shares owned by the BIONOR HOLDING AS

Name	Share class	Total number of shares	Share
B BIONOR IMMUNO AS Under liquidation	Ordinary shares	89,434,932	100 %

Last update: Sep 25, 2026

Group structure

BIONOR HOLDING AS
Total operating income 2024: NOK 0
Operating profit 2024: NOK -80,576
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2021
Total operating income	0	0	0
Annual Total Result	-148,896	-721,526	-3,022,855
Total assets	39,953	43,714	112,376
Total liabilities	859,360	714,225	32,498
Total equity	-819,407	-670,511	79,878

P&L

Year	2024	2023	2021
Total operating income	0	0	0
Total operating costs	80,576	721,882	3,022,436
Operating result	-80,576	-721,882	-3,022,436
Financial income/costs	-68,320	356	-419
Profit before tax	-148,896	-721,526	-3,022,855
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-148,896	-721,526	-3,022,855

Balance overview

Year	2024	2023	2021
Total fixed assets	0	0	0
Total current assets	39,953	43,714	112,376
Total assets	39,953	43,714	112,376
Short term debt	859,360	714,225	32,498
Long term debt	0	0	0
Total liabilities	859,360	714,225	32,498
Contributed capital	26,386,333	26,386,333	22,668,788
Retained earnings	-27,205,740	-27,056,844	-22,588,910
Total equity	-819,407	-670,511	79,878
Total equity and liabilities	39,953	43,714	112,376

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

BIONOR HOLDING AS919 282 134